John P. Schmid, CFO and Secretary at Trius Therapeutics Inc (TSRX), sold 1,200 shares at $9.00 ($11K) on 2011-08-01, disclosed to the SEC on 2011-08-02.
Scheduled sale ($11k) by CFO and Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.78 | 800 | $7K | 66.1% |
| 2 | $9.00 | 400 | $4K | 33.9% |
| Total | $8.85 avg | 1,200 | $11K | 100% |
| Filing → |
| XERS | BUY | 2024-08-13 | $10K | — | Filing → |
| XERS | BUY | 2024-08-12 | $10K | — | Filing → |
| XERS | BUY | 2024-05-10 | $10K | — | Filing → |